Bloating after a salad, or discomfort after a bowl of bran cereal, is familiar to many people with irritable bowel syndrome (IBS), a condition affecting how the gut moves and senses food. People with inflammatory bowel disease (IBD), including Crohn’s disease and ulcerative colitis, can have similar symptoms even when inflammation is under control, making fibre choice a practical daily decision rather than an abstract nutrition question.
What is fibre, and why does the type matter?
Fibre is the part of plant food the small intestine cannot fully digest. It travels further down the gut than most nutrients, interacting with water, gut bacteria, and the muscles that move food along. Soluble fibre dissolves in water to form a gel-like substance, while insoluble fibre does not dissolve and instead adds bulk as it passes through largely intact. This difference is why the two types can affect bloating, cramping, diarrhoea, or constipation quite differently.
Why fibre type matters for gut symptoms
The gut wall has nerve endings that respond to stretching and pressure. Insoluble fibre increases stool bulk, which can speed up transit and relieve constipation, but this bulking effect can worsen cramping or urgency in a gut that is already sensitive or narrowed, relevant for some people with Crohn’s disease. Soluble fibre instead forms a soft gel that slows transit slightly, helps normalise stool consistency, and is fermented more gradually by gut bacteria. This fermentation still produces gas, so soluble fibre is not free of bloating potential, but it tends to be gentler on a gut that reacts strongly to bulk or friction.
Key mechanisms behind fibre’s effects
Water-holding and stool consistency
Soluble fibre, found in oats, psyllium, and peeled apples, absorbs water and swells into a gel. This can firm up loose stools and soften hard ones, so it is often better tolerated across mixed bowel patterns common in IBS.
Bulk and mechanical stretch
Insoluble fibre, found in wheat bran, nuts, and vegetable skins, passes through largely unchanged, adding bulk that stimulates the gut wall to contract and move contents faster. In a sensitive or inflamed gut, this mechanical stretching can trigger pain or urgency rather than relief.
Fermentation and gas production
Gut bacteria ferment fibre in the large intestine to produce short-chain fatty acids, which help maintain the gut lining and a stable microbial environment. Fermentation also produces gas, and highly fermentable fibres can cause more bloating quickly, which is why introducing fibre gradually tends to reduce discomfort.
Transit time and symptom pattern
Because soluble and insoluble fibres affect transit speed differently, the “right” choice often depends on the dominant symptom. Constipation-predominant IBS may benefit from a gradual overall increase in fibre, emphasising soluble sources first. Diarrhoea-predominant symptoms often improve by focusing on soluble fibre while limiting coarse insoluble fibre such as raw bran.
The IBD and IBS overlap
Many people with IBD in remission still experience IBS-type symptoms, thought to relate to ongoing gut sensitivity, altered gut bacteria, or past inflammation affecting gut nerve responses, even without active disease. Fibre choices matter here, but should be considered alongside, not instead of, monitoring for genuine flares. Symptoms such as pain or altered bowel habit don’t automatically mean inflammation has returned, but new or worsening symptoms should always be discussed with a gastroenterologist or IBD team rather than managed by diet alone.
Practical takeaways
- Introduce fibre changes gradually over several weeks, allowing the gut and its bacteria time to adjust.
- If diarrhoea or urgency dominates, prioritise soluble fibre such as oats, psyllium, carrots, and peeled fruit.
- If constipation dominates, build up fibre slowly with both soluble and insoluble sources, increasing fluid intake alongside.
- Keep a simple food and symptom diary to identify which specific fibre sources, rather than fibre generally, trigger discomfort.
- During an IBD flare, seek individualised advice from a dietitian, as tolerance can differ from remission.
- Persistent or new symptoms should be reviewed by a healthcare professional, not assumed to be diet-related.
Conclusion
Soluble and insoluble fibre behave differently in the gut, which helps explain why the same “healthy” food affects two people, or the same person on different days, very differently. For most people with IBS, and many with IBD experiencing functional symptoms in remission, soluble fibre tends to be better tolerated, while insoluble fibre may need more cautious introduction. Fibre choices are a useful day-to-day tool, but work best as part of a stable, personalised long-term plan rather than a quick fix. Any significant or ongoing change in symptoms should be discussed with a gastroenterologist, dietitian, or IBD nurse to rule out other causes.
References
- El-Salhy M, Ystad SO, Mazzawi T, Gundersen D. Dietary fiber in irritable bowel syndrome. Int J Mol Med. 2017;40(3):607-613. doi:10.3892/ijmm.2017.3072
- Nagarajan N, Morden A, Bischof D, et al. The role of fiber supplementation in the treatment of irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2015;27(9):1002-1010. doi:10.1097/MEG.0000000000000425
- McKenzie YA, Bowyer RK, Leach H, et al. British Dietetic Association systematic review and evidence-based practice guidelines for the dietary management of irritable bowel syndrome in adults. J Hum Nutr Diet. 2016;29(5):549-575. doi:10.1111/jhn.12385
- Wilson B, Whelan K. Prebiotic inulin-type fructans and galacto-oligosaccharides: definition, specificity, function, and application in gastrointestinal disorders. J Gastroenterol Hepatol. 2017;32(Suppl 1):64-68. doi:10.1111/jgh.13700
- Cozma-Petruț A, Loghin F, Miere D, Dumitrașcu DL. Diet in irritable bowel syndrome: what to recommend, not what to forbid to patients. World J Gastroenterol. 2017;23(21):3771-3783. doi:10.3748/wjg.v23.i21.3771
- Simrén M, Barbara G, Flint HJ, et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut. 2013;62(1):159-176. doi:10.1136/gutjnl-2012-302167
This article is intended for informational and educational purposes only. It does not constitute medical advice and should not be used as a substitute for professional medical guidance, diagnosis, or treatment.